
Hikal Ltd Stock Falls to 52-Week Low of Rs.180.6 Amid Continued Downtrend
2026-02-06 15:05:06Hikal Ltd’s shares declined sharply to a fresh 52-week low of Rs.180.6 on 6 February 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed its sector and broader market indices, reflecting persistent financial headwinds and subdued performance metrics.
Read full news articleWhen is the next results date for Hikal Ltd?
2026-02-05 23:17:27The next results date for Hikal Ltd is scheduled for 11 February 2026....
Read full news article
Hikal Ltd Opens Strong with Significant Gap Up Reflecting Positive Market Sentiment
2026-02-03 09:44:26Hikal Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 6.84% higher than its previous close, signalling a strong start driven by positive market dynamics within the Pharmaceuticals & Biotechnology sector.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.187.1 Amidst Continued Downtrend
2026-02-02 09:40:27Hikal Ltd’s shares declined to a fresh 52-week low of Rs.187.1 on 2 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects sustained pressures on the company’s financial performance and market sentiment within the Pharmaceuticals & Biotechnology sector.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend
2026-02-01 12:40:07Hikal Ltd’s shares have declined to a fresh 52-week low, closing at Rs 189, just 0.05% above its lowest price in the past year of Rs 188.9. This marks a significant milestone in the stock’s ongoing downward trajectory, reflecting persistent pressures on the company’s financial performance and market valuation.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.188.9 Amidst Continued Downtrend
2026-01-30 10:36:22Hikal Ltd’s shares declined to a fresh 52-week low of Rs.188.9 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.
Read full news article
Hikal Ltd is Rated Strong Sell
2026-01-27 10:10:20Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 January 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.190 Amidst Continued Weak Performance
2026-01-27 09:48:44Hikal Ltd’s shares touched a fresh 52-week low of Rs.190 today, marking a significant decline amid persistent downward momentum. The stock’s performance over the past year has been notably weak, reflecting a combination of financial setbacks and subdued market sentiment within the Pharmaceuticals & Biotechnology sector.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.197.15 Amidst Continued Downtrend
2026-01-23 11:41:09Hikal Ltd’s shares declined to a fresh 52-week low of Rs.197.15 on 23 Jan 2026, marking a significant drop amid a sustained period of underperformance. The stock has now recorded a four-day consecutive fall, losing 6.79% over this span and underperforming its sector by 1.03% today.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04-Feb-2026 | Source : BSEIntimation of Earnings group conference call to discuss the financial and operational performance for the third quarter and nine months ended December 31 2025.
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025
04-Feb-2026 | Source : BSEHikal Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve The unaudited standalone and consolidated financial results for the quarter and nine months ended December 31 2025 and to consider the payment of interim dividend.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Jan-2026 | Source : BSECompliance Certificate Under Regulation 74 (5) of SEBI (DP) Regulations 2018
Corporate Actions
11 Feb 2026
Hikal Ltd has declared 40% dividend, ex-date: 02 Sep 25
Hikal Ltd has announced 2:10 stock split, ex-date: 27 Feb 15
Hikal Ltd has announced 1:2 bonus issue, ex-date: 22 Jun 18
No Rights history available






